FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/109578 [Registered on: 28/04/2026] Trial Registered Prospectively
Last Modified On: 24/04/2026
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   A study to evaluate whether a nutritional supplement containing Cissus quadrangularis helps improve bone fracture healing in adults in India 
Scientific Title of Study   A prospective multicentre real world study to assess the effectiveness and safety of Oral Nutritional Supplement (ONS) containing Cissus Quadrangularis (CQ) in fracture healing in adults with fractures, in India 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rajeev Raman 
Designation  Consultant Orthopaedic 
Affiliation  Joint & Bone Care Hospital 
Address  DD-35, 2nd Avenue, DD Block, Salt Lake City Sector 1

Kolkata
WEST BENGAL
700064
India 
Phone  8420244544  
Fax    
Email  drrajeevraman@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajeev Raman 
Designation  Consultant Orthopaedic 
Affiliation  Joint & Bone Care Hospital 
Address  DD-35, 2nd Avenue, DD Block, Salt Lake City Sector 1

Kolkata
WEST BENGAL
700064
India 
Phone  8420244544  
Fax    
Email  drrajeevraman@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rajeev Raman 
Designation  Consultant Orthopaedic 
Affiliation  Joint & Bone Care Hospital 
Address  DD-35, 2nd Avenue, DD Block, Salt Lake City Sector 1

Kolkata
WEST BENGAL
700064
India 
Phone  8420244544  
Fax    
Email  drrajeevraman@gmail.com  
 
Source of Monetary or Material Support  
Indchemie Health Specialties Pvt Ltd 510, Shah & Nahar Industrial Estate, Dr Elijah Moses Rd, Worli Naka, Mumbai, Maharashtra, 400018 - India 
 
Primary Sponsor  
Name  Indchemie Health Specialties Pvt Ltd 
Address  510 Shah and Nahar Industrial Estate, Dr Elijah Moses Road Worli Naka,Mumbai Maharashtra  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajeev Raman  Joint & Bone Care Hospital  Department of Orthopaedic Room No 1 DD-35 2nd Avenue DD Block Salt Lake City Sector 1 Kolkata west Bengal, 700064
Kolkata
WEST BENGAL 
8420244544

drrajeevraman@gmail.com 
Dr Mahesh Patil  Suman Accident Clinic  Department of Orthopedic, Room No 1, Ganga Complex Phase-A, Above Axis Bank ATM and Bafana Hardware, Opposite Business Bay and Neeta Park Society, Old Airport Road, Yerwada, Pune, 411006
Pune
MAHARASHTRA 
9822000326

drmaheshpatil.22@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Central Independent Ethics Committee  Approved 
Horizon Life Line PVT.LTD  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Fracture 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  Its an Observational Study 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Suffered a fracture- Simple fracture/ Open fractures/ Comminuted fracture

Administered CQ for management of fracture (only/in combination with other medication)

Provide consent to participate

 
 
ExclusionCriteria 
Details  Do not provide consent

Patients with hypercalcemia, Paget disease, malignant tumors, joint dysfunction, and significant polytrauma.

Patients on steroid therapy or immunosuppressants and any other medications affecting bone metabolism.

Pregnant or lactating patients  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effectiveness of oral nutritional supplement containing Cissus Quadrangularis in fracture healing as assessed by
Radiological assessment
Pain
Swelling
Sleep disturbances. 
6 months 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the safety and tolerability of oral nutritional supplement containing Cissus Quadrangularis by monitoring complaints and adverse events.  6 months 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study will use a prospective observational real world study recruiting people with fractures who come for routine care at the study sites and who are treated with Cissus Quadrangularis. They will be recruited for this study after completion of the informed consent process. The recruitment period is for two months. The study is planned as a follow up with a period of four months patient tracking period after recruitment. The primary objective is to evaluate the effectiveness of oral nutritional supplement containing Cissus Quadrangularis in fracture healing as assessed by radiological assessment, pain, swelling and sleep disturbances. 
Close